Q2 FY27 consolidated revenue up 19.6% and profit after tax up 27.4% year on year
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts more than Nifty Smallcap 250 and 4.2 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated Q2 FY27 revenue from operations was INR 873.9 crore versus INR 730.6 crore in Q2 FY26, while profit after tax rose to INR 193.9 crore from INR 152.2 crore. Operating margin before interest, depreciation, tax and other income was 32.1% versus 30.7%. The Board declared a second interim dividend of INR 5 per share and approved up to INR 49.5 crore for the Dubai unit. FY26 earnings per share figures were restated for the 1:1 bonus issue.
Profit growth, wider margins and an INR 5 dividend may support the stock; the Dubai expansion adds cash commitments.
The filed figures for this quarter have not reached us in XBRL yet, so there is nothing to compute here; the read above is the AI's, from the document. The table appears the moment the figures land.